{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:28:59Z","timestamp":1778707739403,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T00:00:00Z","timestamp":1435536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>How neuropeptides in the primate spinal cord regulate itch and pain is largely unknown. Here we elucidate the sensory functions of spinal opioid-related peptides and gastrin-releasing peptide (GRP) in awake, behaving monkeys. Following intrathecal administration, \u03b2-endorphin (10\u2013100\u2009nmol) and GRP (1\u201310\u2009nmol) dose-dependently elicit the same degree of robust itch scratching, which can be inhibited by mu-opioid peptide (MOP) receptor and GRP receptor (BB<jats:sub>2<\/jats:sub>) antagonists, respectively. Unlike \u03b2-endorphin, which produces itch and attenuates inflammatory pain, GRP only elicits itch without affecting pain. In contrast, enkephalins (100\u20131000\u2009nmol) and nociceptin-orphanin FQ (3\u201330\u2009nmol) only inhibit pain without eliciting itch. More intriguingly, dynorphin A(1\u201317) (10\u2013100\u2009nmol) dose-dependently attenuates both \u03b2-endorphin- and GRP-elicited robust scratching without affecting pain processing. The anti-itch effects of dynorphin A can be reversed by a kappa-opioid peptide (KOP) receptor antagonist nor-binaltorphimine. These nonhuman primate behavioral models with spinal delivery of ligands advance our understanding of distinct functions of neuropeptides for modulating itch and pain. In particular, we demonstrate causal links for itch-eliciting effects by \u03b2-endorphin-MOP receptor and GRP-BB<jats:sub>2<\/jats:sub>receptor systems and itch-inhibiting effects by the dynorphin A-KOP receptor system. These studies will facilitate transforming discoveries of novel ligand-receptor systems into future therapies as antipruritics and\/or analgesics in humans.<\/jats:p>","DOI":"10.1038\/srep11676","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T11:13:20Z","timestamp":1435576400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates"],"prefix":"10.1038","volume":"5","author":[{"given":"Heeseung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chuan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,29]]},"reference":[{"key":"BFsrep11676_CR1","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","volume":"368","author":"G Yosipovitch","year":"2013","unstructured":"Yosipovitch, G. & Bernhard, J. D. Clinical practice. Chronic pruritus. N Engl J Med 368, 1625\u20131634 (2013).","journal-title":"N Engl J Med"},{"key":"BFsrep11676_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cld.2008.02.013","volume":"12","author":"NV Bergasa","year":"2008","unstructured":"Bergasa, N. V. Pruritus in primary biliary cirrhosis: pathogenesis and therapy. Clin Liver Dis 12, 385\u2013406; x (2008).","journal-title":"Clin Liver Dis"},{"key":"BFsrep11676_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.5301\/jn.5000039","volume":"25","author":"LW Kfoury","year":"2012","unstructured":"Kfoury, L. W. & Jurdi, M. A. Uremic pruritus. J Nephrol 25, 644\u2013652 (2012).","journal-title":"J Nephrol"},{"key":"BFsrep11676_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","volume":"37","author":"R Terg","year":"2002","unstructured":"Terg, R., Coronel, E., Sorda, J., Munoz, A. E. & Findor, J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 37, 717\u2013722 (2002).","journal-title":"J Hepatol"},{"key":"BFsrep11676_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/0024-3205(93)90569-O","volume":"53","author":"NV Bergasa","year":"1993","unstructured":"Bergasa, N. V., Thomas, D. A., Vergalla, J., Turner, M. L. & Jones, E. A. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. Life Sci 53, 1253\u20131257 (1993).","journal-title":"Life Sci"},{"key":"BFsrep11676_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.peptides.2014.09.013","volume":"62","author":"RJ Bodnar","year":"2014","unstructured":"Bodnar, R. J. Endogenous opiates and behavior: 2013. Peptides 62, 67\u2013136 (2014).","journal-title":"Peptides"},{"key":"BFsrep11676_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00000542-200003000-00023","volume":"92","author":"MC Ko","year":"2000","unstructured":"Ko, M. C. & Naughton, N. N. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology 92, 795\u2013805 (2000).","journal-title":"Anesthesiology"},{"key":"BFsrep11676_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/jpet.108.143925","volume":"328","author":"MC Ko","year":"2009","unstructured":"Ko, M. C. & Husbands, S. M. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 328, 193\u2013200 (2009).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR9","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2165\/00003495-200767160-00003","volume":"67","author":"A Ganesh","year":"2007","unstructured":"Ganesh, A. & Maxwell, L. G. Pathophysiology and management of opioid-induced pruritus. Drugs 67, 2323\u20132333 (2007).","journal-title":"Drugs"},{"key":"BFsrep11676_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrn2947","volume":"11","author":"AJ Todd","year":"2010","unstructured":"Todd, A. J. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11, 823\u2013836 (2010).","journal-title":"Nat Rev Neurosci"},{"key":"BFsrep11676_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nn.3619","volume":"17","author":"DM Bautista","year":"2014","unstructured":"Bautista, D. M., Wilson, S. R. & Hoon, M. A. Why we scratch an itch: the molecules, cells and circuits of itch. Nat Neurosci 17, 175\u2013182 (2014).","journal-title":"Nat Neurosci"},{"key":"BFsrep11676_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrn3641","volume":"15","author":"RH LaMotte","year":"2014","unstructured":"LaMotte, R. H., Dong, X. & Ringkamp, M. Sensory neurons and circuits mediating itch. Nat Rev Neurosci 15, 19\u201331 (2014).","journal-title":"Nat Rev Neurosci"},{"key":"BFsrep11676_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.107.07108","volume":"60","author":"RT Jensen","year":"2008","unstructured":"Jensen, R. T., Battey, J. F., Spindel, E. R. & Benya, R. V. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling and functions in normal and disease states. Pharmacol Rev 60, 1\u201342 (2008).","journal-title":"Pharmacol Rev"},{"key":"BFsrep11676_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0014-2999(93)90860-K","volume":"238","author":"A Masui","year":"1993","unstructured":"Masui, A. et al. Scratching behavior induced by bombesin-related peptides. Comparison of bombesin, gastrin-releasing peptide and phyllolitorins. Eur J Pharmacol 238, 297\u2013301 (1993).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep11676_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature06029","volume":"448","author":"YG Sun","year":"2007","unstructured":"Sun, Y. G. & Chen, Z. F. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448, 700\u2013703 (2007).","journal-title":"Nature"},{"key":"BFsrep11676_CR16","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/jid.2013.166","volume":"133","author":"LA Nattkemper","year":"2013","unstructured":"Nattkemper, L. A. et al. Overexpression of the gastrin-releasing peptide in cutaneous nerve fibers and its receptor in the spinal cord in primates with chronic itch. J Invest Dermatol 133, 2489\u20132492 (2013).","journal-title":"J Invest Dermatol"},{"key":"BFsrep11676_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/jid.2013.38","volume":"133","author":"S Kagami","year":"2013","unstructured":"Kagami, S. et al. Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis. J Invest Dermatol 133, 1673\u20131675 (2013).","journal-title":"J Invest Dermatol"},{"key":"BFsrep11676_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm1595","volume":"13","author":"G Courtine","year":"2007","unstructured":"Courtine, G. et al. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med 13, 561\u2013566 (2007).","journal-title":"Nat Med"},{"key":"BFsrep11676_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/cn300124f","volume":"4","author":"AP Lin","year":"2013","unstructured":"Lin, A. P. & Ko, M. C. The therapeutic potential of nociceptin\/orphanin FQ receptor agonists as analgesics without abuse liability. ACS Chem Neurosci 4, 214\u2013224 (2013).","journal-title":"ACS Chem Neurosci"},{"key":"BFsrep11676_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajp.22281","volume":"76","author":"KA Phillips","year":"2014","unstructured":"Phillips, K. A. et al. Why primate models matter. Am J Primatol 76, 801\u2013827 (2014).","journal-title":"Am J Primatol"},{"key":"BFsrep11676_CR21","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1073\/pnas.0905605106","volume":"106","author":"N Imamachi","year":"2009","unstructured":"Imamachi, N. et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci USA 106, 11330\u201311335 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep11676_CR22","doi-asserted-by":"publisher","first-page":"e100610","DOI":"10.1371\/journal.pone.0100610","volume":"9","author":"RA Gibson","year":"2014","unstructured":"Gibson, R. A. et al. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine and cowhage challenge in healthy volunteers. PLoS One 9, e100610 (2014).","journal-title":"PLoS One"},{"key":"BFsrep11676_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00008877-200311000-00002","volume":"14","author":"H Lee","year":"2003","unstructured":"Lee, H., Naughton, N. N., Woods, J. H. & Ko, M. C. Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behav Pharmacol 14, 501\u2013508 (2003).","journal-title":"Behav Pharmacol"},{"key":"BFsrep11676_CR24","doi-asserted-by":"publisher","first-page":"e67422","DOI":"10.1371\/journal.pone.0067422","volume":"8","author":"DD Sukhtankar","year":"2013","unstructured":"Sukhtankar, D. D. & Ko, M. C. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PLoS One 8, e67422 (2013).","journal-title":"PLoS One"},{"key":"BFsrep11676_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01.anes.0000278876.20263.a7","volume":"107","author":"H Lee","year":"2007","unstructured":"Lee, H., Naughton, N. N., Woods, J. H. & Ko, M. C. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 107, 478\u2013485 (2007).","journal-title":"Anesthesiology"},{"key":"BFsrep11676_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00540-012-1421-7","volume":"26","author":"Z Wu","year":"2012","unstructured":"Wu, Z., Kong, M., Wang, N., Finlayson, R. J. & Tran, Q. H. Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blind, placebo-controlled study. J Anesth 26, 752\u2013757 (2012).","journal-title":"J Anesth"},{"key":"BFsrep11676_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","volume":"148","author":"E Hu","year":"2010","unstructured":"Hu, E., Calo, G., Guerrini, R. & Ko, M. C. Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112. Pain 148, 107\u2013113 (2010).","journal-title":"Pain"},{"key":"BFsrep11676_CR28","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/jpet.106.106120","volume":"318","author":"MC Ko","year":"2006","unstructured":"Ko, M. C., Wei, H., Woods, J. H. & Kennedy, R. T. Effects of intrathecally administered nociceptin\/orphanin FQ in monkeys: behavioral and mass spectrometric studies. J Pharmacol Exp Ther 318, 1257\u20131264 (2006).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(25)20059-3","volume":"232","author":"BH Herman","year":"1985","unstructured":"Herman, B. H. & Goldstein, A. Antinociception and paralysis induced by intrathecal dynorphin A. J Pharmacol Exp Ther 232, 27\u201332 (1985).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.102.044909","volume":"305","author":"MC Ko","year":"2003","unstructured":"Ko, M. C. et al. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J Pharmacol Exp Ther 305, 173\u2013179 (2003).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00213-013-3341-0","volume":"231","author":"DD Sukhtankar","year":"2014","unstructured":"Sukhtankar, D. D., Lee, H., Rice, K. C. & Ko, M. C. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain. Psychopharmacology (Berl) 231, 1377\u20131387 (2014).","journal-title":"Psychopharmacology (Berl)"},{"key":"BFsrep11676_CR32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(24)37585-8","volume":"286","author":"A Alt","year":"1998","unstructured":"Alt, A. et al. Stimulation of guanosine-5\u2019-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. J Pharmacol Exp Ther 286, 282\u2013288 (1998).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.pharmtox.42.091401.113012","volume":"42","author":"T Kenakin","year":"2002","unstructured":"Kenakin, T. Drug efficacy at G protein-coupled receptorreceptors. Annu Rev Pharmacol Toxicol 42, 349\u2013379 (2002).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFsrep11676_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1124\/jpet.103.061101","volume":"310","author":"MC Ko","year":"2004","unstructured":"Ko, M. C., Song, M. S., Edwards, T., Lee, H. & Naughton, N. N. The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 310, 169\u2013176 (2004).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","volume":"147","author":"XY Liu","year":"2011","unstructured":"Liu, X. Y. et al. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147, 447\u2013458 (2011).","journal-title":"Cell"},{"key":"BFsrep11676_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","volume":"88","author":"D Peckys","year":"1999","unstructured":"Peckys, D. & Landwehrmeyer, G. B. Expression of mu, kappa and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience 88, 1093\u20131135 (1999).","journal-title":"Neuroscience"},{"key":"BFsrep11676_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2012.01.013","volume":"124","author":"J Peng","year":"2012","unstructured":"Peng, J., Sarkar, S. & Chang, S. L. Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 124, 223\u2013228 (2012).","journal-title":"Drug Alcohol Depend"},{"key":"BFsrep11676_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1021\/bk-2013-1131.ch015","volume":"ACS Symposium S","author":"G Calo\u2019","year":"2013","unstructured":"Calo\u2019, G. & Guerrini, R. Medicinal chemistry, pharmacology and biological actions of peptide ligands selective for the nociceptin\/orphanin FQ receptor. in Research and Development of Opioid-Related Ligands, ACS Symposium Series 1131 (eds. Ko, M. C. & Husbands, S. M. ) 275\u2013325 (American Chemical Society, Washington DC, USA, 2013).","journal-title":"Research and Development of Opioid-Related Ligands"},{"key":"BFsrep11676_CR39","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1111\/bph.12744","volume":"171","author":"W Schroder","year":"2014","unstructured":"Schroder, W., Lambert, D. G., Ko, M. C. & Koch, T. Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists. Br J Pharmacol 171, 3777\u20133800 (2014).","journal-title":"Br J Pharmacol"},{"key":"BFsrep11676_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/(SICI)1096-9861(19980928)399:3<373::AID-CNE6>3.0.CO;2-Y","volume":"399","author":"G Monteillet-Agius","year":"1998","unstructured":"Monteillet-Agius, G., Fein, J., Anton, B. & Evans, C. J. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J Comp Neurol 399, 373\u2013383 (1998).","journal-title":"J Comp Neurol"},{"key":"BFsrep11676_CR41","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/jpet.111.178970","volume":"337","author":"PY Su","year":"2011","unstructured":"Su, P. Y. & Ko, M. C. The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats. J Pharmacol Exp Ther 337, 822\u2013829 (2011).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1744-8069-10-44","volume":"10","author":"SC Goswami","year":"2014","unstructured":"Goswami, S. C. et al. Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia and the spinal cord. Mol Pain 10, 44 (2014).","journal-title":"Mol Pain"},{"key":"BFsrep11676_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2005.06.025","volume":"518","author":"S Inan","year":"2005","unstructured":"Inan, S. & Cowan, A. Reduced kappa-opioid activity in a rat model of cholestasis. Eur J Pharmacol 518, 182\u2013186 (2005).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep11676_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuron.2014.02.046","volume":"82","author":"AP Kardon","year":"2014","unstructured":"Kardon, A. P., et al. Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord. Neuron 82, 573\u2013586 (2014).","journal-title":"Neuron"},{"key":"BFsrep11676_CR45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(25)21347-7","volume":"230","author":"DE Gmerek","year":"1984","unstructured":"Gmerek, D. E. & Cowan, A. In vivo evidence for benzomorphan-selective receptors in rats. J Pharmacol Exp Ther 230, 110\u2013115 (1984).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(25)39577-7","volume":"267","author":"ER Butelman","year":"1993","unstructured":"Butelman, E. R., Negus, S. S., Ai, Y., de Costa, B. R. & Woods, J. H. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267, 1269\u20131276 (1993).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(24)35216-4","volume":"291","author":"MC Ko","year":"1999","unstructured":"Ko, M. C. et al. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. J Pharmacol Exp Ther 291, 1113\u20131120 (1999).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep11676_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000341268","volume":"36","author":"H Kumagai","year":"2012","unstructured":"Kumagai, H. et al. Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol 36, 175\u2013183 (2012).","journal-title":"Am J Nephrol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep11676","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep11676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep11676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:28:52Z","timestamp":1748471332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep11676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,18]]}},"alternative-id":["BFsrep11676"],"URL":"https:\/\/doi.org\/10.1038\/srep11676","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,29]]},"assertion":[{"value":"20 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11676"}}